Record #2879
A quantitative approach to benefit-risk assessment of medicines--part 2; the practical application of a new model
Publisher
Original paper date
Jun 1, 2007
Original DOI
Country
Institution
Regulatory Affairs Europe, Merck Sharp & Dohme (Europe) Inc, 5 Lynx Binnenhof, Brussels, B-1200, Belgium · Centre for Socioeconomic Research, Welsh School of Pharmacy, Redwood Building, King Edward VII Avenue, Cardiff, CF10 3XF · CMR International, Novellus Court, 61 South Street, Epsom, Surrey, KT18 7PX
Open access
No
Article type
Citation lifecycle
How this paper is being cited
Pre-retraction
1
Same day
0
Post-retraction
18
% post-retraction
94.7%
~3.0 citations/yr before retraction · ~0.9 citations/yr after
— citing papers
Who is still citing this work
Loading…